|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
Avonex from IDEC Pharmaceuticals
Zolgensma from Novartis
|
|
gptkbp:ceo
|
gptkb:Michel_Vounatsos
|
|
gptkbp:clinical_trial
|
gptkb:psychologist
Multiple sclerosis
Spinal muscular atrophy
|
|
gptkbp:employees
|
7,500 (2020)
|
|
gptkbp:founded
|
gptkb:1988
|
|
gptkbp:founder
|
gptkb:M._A._(Marty)_Kauffman
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
Cambridge, Massachusetts, USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bio Gen Corp
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:key_people
|
gptkb:David_Meeker
gptkb:Richard_A._Heyman
gptkb:Michel_Vounatsos
gptkb:M._A._(Marty)_Kauffman
gptkb:Alfred_Sandrock
gptkb:Paul_Clancy
Michael Ehlers
David M. Mott
Gail M. Mc Gowan
Robert W. Pomeroy
Stuart Peltz
|
|
gptkbp:partnership
|
gptkb:Samsung_Bio_Logics
gptkb:Roche
|
|
gptkbp:products
|
gptkb:Tecfidera
gptkb:Spinraza
gptkb:Avonex
gptkb:Alecensa
|
|
gptkbp:revenue
|
$11.4 billion (2020)
|
|
gptkbp:stock_exchange
|
gptkb:NASDAQ
|
|
gptkbp:subsidiary
|
gptkb:Bioverativ
gptkb:Ionis_Pharmaceuticals
|
|
gptkbp:symbol
|
gptkb:BIIB
|
|
gptkbp:website
|
www.biogen.com
|
|
gptkbp:bfsParent
|
gptkb:Gen_Tech_Labs
gptkb:Sparrow_Laboratories
|
|
gptkbp:bfsLayer
|
7
|